Abstract
Italy was the first western nation affected by the pandemic and was observed as a pilot case in the management of the new coronavirus epidemic. The outbreak of COVID-19 disease has been challenging in Italy. On June 25, 2020 there were 239,821 total cases, of which 33,592 were deaths nationwide. Three lessons emerged from this experience that can serve as a blueprint to improve future plans for the outbreak of viruses. First, early reports on the spread of COVID-19 can help inform public health officials and medical practitioners in effort to combat its progression; second, inadequate risk assessment related to the urgency of the situation and limited reporting to the virus has led the rapid spread of COVID-19; third, an effective response to the virus had to be undertaken with coherent system of actions simultaneously.
Keywords: COVID-19 pandemic in Italy, first cases, risk assessment, coherent system of actions, lessons learned, human parainfluenza virus (HPIV).
Coronaviruses
Title:Dealing with COVID-19: Lessons Learned from the Italian Experience
Volume: 2 Issue: 1
Author(s): Silvana Mirella Aliberti*, Francesco De Caro, Giovanni Boccia, Rosario Caruso and Mario Capunzo
Affiliation:
- Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, Fisciano,Italy
Keywords: COVID-19 pandemic in Italy, first cases, risk assessment, coherent system of actions, lessons learned, human parainfluenza virus (HPIV).
Abstract: Italy was the first western nation affected by the pandemic and was observed as a pilot case in the management of the new coronavirus epidemic. The outbreak of COVID-19 disease has been challenging in Italy. On June 25, 2020 there were 239,821 total cases, of which 33,592 were deaths nationwide. Three lessons emerged from this experience that can serve as a blueprint to improve future plans for the outbreak of viruses. First, early reports on the spread of COVID-19 can help inform public health officials and medical practitioners in effort to combat its progression; second, inadequate risk assessment related to the urgency of the situation and limited reporting to the virus has led the rapid spread of COVID-19; third, an effective response to the virus had to be undertaken with coherent system of actions simultaneously.
Export Options
About this article
Cite this article as:
Aliberti Mirella Silvana *, De Caro Francesco, Boccia Giovanni , Caruso Rosario and Capunzo Mario , Dealing with COVID-19: Lessons Learned from the Italian Experience, Coronaviruses 2021; 2 (1) . https://dx.doi.org/10.2174/2666796701999200908094136
DOI https://dx.doi.org/10.2174/2666796701999200908094136 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Patentable Use of an Old Neuroleptic Compound Thioridazine to Combat Tuberculosis: A Gene Regulation Perspective
Recent Patents on Anti-Infective Drug Discovery Impact of COVID-19 on Gender Equality, Sexual and Reproductive Health Rights of Adolescent Girls and Young Women: A Narrative Review
Current Women`s Health Reviews Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19)
Mini-Reviews in Medicinal Chemistry Diagnosis and Possible Use of Traditional Medicinal Plant to combat COVID-19
Coronaviruses Covid-19 Susceptibility and Severity Might be Modified by Vitamin D Status: Theoretical and Practical Considerations
Current Respiratory Medicine Reviews Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak
Mini-Reviews in Medicinal Chemistry The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19
Current Stem Cell Research & Therapy Synthetic Lung Surfactant Treatment for COVID-19 Pneumonia
Coronaviruses Intercorrelation of Major DNA/RNA Sequence Descriptors - A Preliminary Study
Current Computer-Aided Drug Design Recent Patents on Cell Cycle Regulatory Proteins
Recent Patents on Biotechnology Virtual High Throughput Screening to find Suitable Inhibitors for SARSCoV- 2 Main Protease
Anti-Infective Agents New Viral Infection COVID-19: Current Status, Challenges and Possible Treatments
Letters in Drug Design & Discovery Discovery of Potent Anti-SARS-CoV MPro Inhibitors
Current Computer-Aided Drug Design A Mini Review on Emerging Targets and Approaches for the Synthesis of Anti-viral Compounds: In Perspective to COVID-19
Mini-Reviews in Medicinal Chemistry Recent Advances in Natural Products with Antiviral Activities
Mini-Reviews in Medicinal Chemistry Sensitivity of SARS/MERS CoV to Interferons and Other Drugs Based on Achievable Serum Concentrations in Humans
Infectious Disorders - Drug Targets Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews Efficacy of Dexamethasone for the Treatment of COVID-19 Infection: A Perspective Review
Current Drug Delivery Quaternary Structure, Substrate Selectivity and Inhibitor Design for SARS 3C-Like Proteinase
Current Pharmaceutical Design Editorial: From Perfume Oils to Discovering and Making New Molecules: An International Chemical Biology Journey
Combinatorial Chemistry & High Throughput Screening